334 related articles for article (PubMed ID: 8778223)
21. Differential coupling with pertussis toxin-sensitive G proteins of dopamine and somatostatin receptors involved in regulation of adenohypophyseal secretion.
Musset F; Bertrand P; Kordon C; Enjalbert A
Mol Cell Endocrinol; 1990 Oct; 73(1):1-10. PubMed ID: 1981365
[TBL] [Abstract][Full Text] [Related]
22. The stimulatory and inhibitory effects of quinpirole hydrochloride, D2-dopamine receptor agonist, on secretion of prolactin as assessed by the reverse hemolytic plaque assay.
Niimi M; Takahara J; Sato M; Murao K; Kawanishi K
Life Sci; 1993; 53(4):305-13. PubMed ID: 8100980
[TBL] [Abstract][Full Text] [Related]
23. Role of vasoactive intestinal peptide and 5-HT2 receptor subtype in serotonin stimulation of basal and thyrotropin-releasing-hormone-induced prolactin release in vitro from rat pituitary cells.
Apfelbaum ME
Neuroendocrinology; 1998 Jan; 67(1):45-50. PubMed ID: 9485168
[TBL] [Abstract][Full Text] [Related]
24. Low concentrations of dopamine increase cytosolic calcium in lactotrophs.
Burris TP; Freeman ME
Endocrinology; 1993 Jul; 133(1):63-8. PubMed ID: 8391429
[TBL] [Abstract][Full Text] [Related]
25. Regulation of prolactin secretion by dopamine and thyrotropin-releasing hormone in lactating rat adenohypophyses: influence of intracellular age of the hormone.
Mena F; Clapp C; Aguayo D; Morales MT; Grosvenor CE; Martínez de la Escalera G
Endocrinology; 1989 Oct; 125(4):1814-20. PubMed ID: 2507284
[TBL] [Abstract][Full Text] [Related]
26. Transient dopamine withdrawal differentially potentiates thyrotropin releasing hormone-induced release of prolactin of various ages.
Martinez de la Escalera G; Weiner RI
Neuroendocrinology; 1990 Jun; 51(6):694-9. PubMed ID: 2114004
[TBL] [Abstract][Full Text] [Related]
27. The cortical actin cytoskeleton of lactotropes as an intracellular target for the control of prolactin secretion.
Carbajal ME; Vitale ML
Endocrinology; 1997 Dec; 138(12):5374-84. PubMed ID: 9389523
[TBL] [Abstract][Full Text] [Related]
28. The stimulatory and inhibitory effects of dopamine on prolactin secretion involve different G-proteins.
Burris TP; Nguyen DN; Smith SG; Freeman ME
Endocrinology; 1992 Feb; 130(2):926-32. PubMed ID: 1733734
[TBL] [Abstract][Full Text] [Related]
29. Stimulatory effects of quinpirole hydrochloride, D2-dopamine receptor agonist, at low concentrations on prolactin release in female rats in vitro.
Tagawa R; Takahara J; Sato M; Niimi M; Murao K; Ishida T
Life Sci; 1992; 51(10):727-32. PubMed ID: 1355255
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of protein phosphatase 2A (PP2A) mimics suckling-induced sensitization of mammotropes: involvement of a pertussis toxin (PTX) sensitive G-protein and the adenylate cyclase (AC).
Horváth KM; Radnai B; Béla TE; Fekete MI; Nagy GM
Mol Cell Endocrinol; 1999 Mar; 149(1-2):1-7. PubMed ID: 10375012
[TBL] [Abstract][Full Text] [Related]
31. Transient removal of dopamine potentiates the stimulation of prolactin release by TRH but not VIP: stimulation via Ca2+/protein kinase C pathway.
Martínez de la Escalera G; Guthrie J; Weiner RI
Neuroendocrinology; 1988 Jan; 47(1):38-45. PubMed ID: 3124014
[TBL] [Abstract][Full Text] [Related]
32. Fibroblast growth factor-2 and epidermal growth factor modulate prolactin responses to TRH and dopamine in primary cultures.
Spuch C; Diz-Chaves Y; Pérez-Tilve D; Mallo F
Endocrine; 2006 Apr; 29(2):317-24. PubMed ID: 16785607
[TBL] [Abstract][Full Text] [Related]
33. Interaction between salsolinol (SAL) and thyrotropin-releasing hormone (TRH) or dopamine (DA) on the secretion of prolactin in ruminants.
Hashizume T; Shida R; Suzuki S; Kasuya E; Kuwayama H; Suzuki H; Oláh M; Nagy GM
Domest Anim Endocrinol; 2008 Apr; 34(3):327-32. PubMed ID: 17976947
[TBL] [Abstract][Full Text] [Related]
34. Thyrotropin-releasing hormone and gonadotropin-releasing hormone-associated peptide modulation of [Ca2+]i in human lactotrophs.
Dufy-Barbe L; Bresson L; Vacher P; Odessa MF; San Galli F; Rivel J; Guérin J
Mol Cell Endocrinol; 1993 Sep; 95(1-2):67-74. PubMed ID: 8243809
[TBL] [Abstract][Full Text] [Related]
35. Thyrotropin regulates thyrotroph responsiveness to dopamine in vitro.
Foord SM; Peters JR; Dieguez C; Shewring G; Hall R; Scanlon MF
Endocrinology; 1986 Apr; 118(4):1319-26. PubMed ID: 3004910
[TBL] [Abstract][Full Text] [Related]
36. Influence of dopamine on the altered release of prolactin, luteinizing hormone, and follicle-stimulating hormone induced by interleukin-2 in vitro.
Karanth S; Marubayashi U; McCann SM
Neuroendocrinology; 1992 Dec; 56(6):871-80. PubMed ID: 1369597
[TBL] [Abstract][Full Text] [Related]
37. The effect of transient dopamine antagonism on thyrotropin-releasing hormone-induced prolactin release in pregnant rats.
Haisenleder DJ; Moy JA; Gala RR; Lawson DM
Endocrinology; 1986 Nov; 119(5):1980-8. PubMed ID: 3095096
[TBL] [Abstract][Full Text] [Related]
38. Role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in the control of prolactin, growth hormone and gonadotropin secretion in prepubertal rats.
González LC; Pinilla L; Tena-Sempere M; Aguilar E
J Endocrinol; 1999 Sep; 162(3):417-24. PubMed ID: 10467233
[TBL] [Abstract][Full Text] [Related]
39. Differential inhibition of dopamine and bromocriptine on induced prolactin release: multiple sites for the inhibition of dopamine.
Hanna S; Shin SH
Neuroendocrinology; 1992 May; 55(5):591-9. PubMed ID: 1316563
[TBL] [Abstract][Full Text] [Related]
40. Effects of VIP, TRH, GABA and dopamine on prolactin release from superfused rat anterior pituitary cells.
Matsushita N; Kato Y; Shimatsu A; Katakami H; Yanaihara N; Imura H
Life Sci; 1983 Mar; 32(11):1263-9. PubMed ID: 6132313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
